Results 1 to 18 of 18
Page 1 of 1
TypeTitleAuthor(s)YearViews
Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis BLai, CL; Ahn, SH; Lee, KS; Um, SH; Cho, M; Yoon, SK; Lee, JW; Park, NH; Kweon, YO; Sohn, JH; Lee, J; Kim, JA; Han, KH; Yuen, RMF201321
 
Digestive cancer management in Asia: position statements: a report on GI Oncology Summit in 2011Sung, JJ; Ng, EK; Lin, JT; Ho, KY; Ji, JF; Sugano, K; Poon, RTP; Chan, AT; Goh, KL; Han, KH; Chen, LL; Wu, KC; Ng, SS; Bresalier, RS; Chan, FK; Yau, TCC201233
 
No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations.Sawai, H; Nishida, N; Mbarek, H; Matsuda, K; Mawatari, Y; Yamaoka, M; Hige, S; Kang, JH; Abe, K; Mochida, S; Watanabe, M; Kurosaki, M; Asahina, Y; Izumi, N; Honda, M; Kaneko, S; Tanaka, E; Matsuura, K; Itoh, Y; Mita, E; Korenaga, M; Hno, K; Murawaki, Y; Hiasa, Y; Ide, T; Ito, K; Sugiyama, M; Ahn, SH; Han, KH; Park, JY; Yuen, RMF; Nakamura, Y; Tanaka, Y; Mizokami, M; Mizokami, M; Tokunaga, K201284
 
Asian consensus workshop report: Expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in AsiaHan, KH; Kudo, M; Ye, SL; Choi, JY; Poon, RTP; Seong, J; Park, JW; Ichida, T; Chung, JW; Chow, P; Cheng, AL2011105
 
Week 48 analysis of a Phase IIB study of the efficacy and safety of LB80380 vs. entecavir in treatment-naive patients with chronic Hepatitis BLai, CL; Ahh, SH; Lee, KS; Um, SH; Cho, M; Yoon, SK; Lee, JW; Park, NH; Kweon, YO; Sohn, JH; Lee, J; Kim, JA; Han, KH; Yuen, MF2011108
 
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): Development and validation of a predictive scoreYang, HI; Yuen, MF; Chan, HLY; Han, KH; Chen, PJ; Kim, DY; Ahn, SH; Chen, CJ; Wong, VWS; Seto, WK2011967
 
A phase IIb study of the efficacy and safety of LB80380 vs entecavir in treatment-naive patients with chronic hepatitis BLai, CL; Ahn, SH; Lee, KS; Um, SH; Cho, M; Yoon, SK; Lee, JW; Park, NW; Kwon, YO; Sohn, JH; Lee, JY; Park, HE; Kim, JA; Han, KH; Yuen, MF2011232
 
Efficacy of entecavir in chronic hepatitis b patients with mildly elevated alanine aminotransferase and biopsy-proven histological damageWu, IC; Lai, CL; Bui Han, SH; Han, KH; Gordon, SC; Chao, YC; Tan, CK; Sievert, W; Tanwandee, T; Xu, D; Neo, BL; Chang, TT201086
 
Antiviral activity and safety of LB80380 in hepatitis B e antigen-positive chronic hepatitis B patients with lamivudine-resistant diseaseYuen, MF; Han, KH; Um, SH; Yoon, SK; Kim, HR; Kim, J; Kim, CR; Lai, CL201097
 
Liver cancer working group reportKudo, M; Han, KH; Kokudo, N; Cheng, AL; Choi, BI; Furuse, J; Izumi, N; Park, JW; Poon, RT; Sakamoto, M2010332
 
Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis BChang, TT; Liaw, YF; Wu, SS; Schiff, E; Han, KH; Lai, CL; Safadi, R; Lee, SS; Halota, W; Goodman, Z; Chi, YC; Zhang, H; Hindes, R; Iloeje, U; Beebe, S; Kreter, B2010130
 
Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinomaOmata, M; Lesmana, LA; Tateishi, R; Chen, PJ; Lin, SM; Yoshida, H; Kudo, M; Lee, JM; Choi, BI; Poon, RTP; Shiina, S; Cheng, AL; Jia, JD; Obi, S; Han, KH; Jafri, W; Chow, P; Lim, SG; Chawla, YK; Budihusodo, U; Gani, RA; Lesmana, CR; Putranto, TA; Liaw, YF; Sarin, SK2010130
 
Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific RegionAmarapurkar, D; Han, KH; Chan, HLY; Ueno, Y; Yuen, RMF2009323
 
Efficacy of entecavir in nucleoside-naefve patients with mildly elevated ALTGordon, SC; Han, SH; Chang, TT; Lai, CL; Han, KH; Chao, YC; Tan, CK; Sievert, W; Tanwandee, T; Neo, BL2008108
 
Errata: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 updateLiaw, YF; Leung, N; Kao, JH; Piratvisuth, T; Gane, E; Han, KH; Guan, R; Lau, GKK; Locarnini, S; The Chronic Hepatitis B Guideline Working Party of the Asian-Pacific Association for the Study of the Liver2008129
 
Long-term entecavir therapy results in reversal of fibrosis/cirrhosis and continued histologic improvement in patients with HBeAg(+) and (-) chronic hepatitis B: results from studies ETV-022, -027 and -901.Liaw, YF; Chang, TT; Wu, SS; Schiff, ER; Han, KH; Lai, CL; Safadi, R; Lee, SS; Halota, W; Goodman, ZD; Zhang, H; Hindes, R; Hoeje, U; Beebe, S; Kreter, B2008202
 
Phase II multi-centre, dose-escalating study of LB80380 (ANA380) in hepatitis B patients with lamivudine-resistant YMDD mutant HBVLai, CL; Han, KH; Yoon, SK; Um, SH; Yuen, MF; Kim, HS; Kim, HR; Chung, HC; Kim, CR; Hsyu, P; Averett, D; Worland, S; Kim, J2006207
 
Role of nicotinic acid in raising high-density lipoprotein cholesterol (HDL-C) to reduce cardiovascular risk: An Asian/Pacific consensusBarter, PJ; O'Brien, R; Watts, GF; Zhu, J; Hu, D; Ho, CC; Tomlinson, B; Cheung, BMY; Adam, JMF; Tjokroprawiro, A; Waspadji, S; Cho, HK; Han, KH; Kim, SR; Lin, KK; Chan, SP; Basit, A; PizzaroBorromeo, AB; PazPacheco, E; Sy, RG; Lee, KO; Low, LP; Khue, NT; Binh, TV2005145
 
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download